Elanco is operating with momentum and disciplined execution.
Elanco’s stock trades on the New York Stock Exchange (NYSE).
Elanco’s ticker symbol is “ELAN”.
Elanco has authorized Computershare Trust Company, N.A. as its transfer agent.
Transfer agents maintain stock registries for their client companies such as Elanco. They assist with account information and updates, processing and paying dividends, registration changes, transferring stock, and answering questions from shareholders about their accounts.
You may contact Computershare by calling: (800) 736-3001 (US, Canada, Puerto Rico) (781) 575-3100 (non-US)
Correspondence should be mailed to: Computershare P.O. Box 505000 Louisville, KY 40233-5000
Overnight correspondence should be mailed to: Computershare 462 South 4th Street, Suite 1600 Louisville KY 40202
Be sure to include your name, address, day time phone number, account number, company name (as shown on your statement) on all correspondence.
E-mail and online inquiries may be directed to: Email Inquiries: web.queries@computershare.com Online Inquiries: https://www-us.computershare.com/investor/Contact
We do not anticipate paying dividends on our common stock in the foreseeable future.
At this time, Elanco does not have a dividend reinvestment plan.
Contact our investor relations department by mail at: Elanco Animal Health Incorporated Attn: Investor Relations Department 2500 Innovation Way Greenfield, IN 46140 Or contact by email at investor@elanco.com
Elanco’s corporate offices are located at: 2500 Innovation Way Greenfield, IN 46140
Elanco’s fiscal year ends on December 31.
Ernst & Young serves as the company’s independent auditors.
Elanco finalized the acquisition of Aratana Therapeutics on July 18, 2019. At the close of the stock-for-stock transaction, Aratana stockholders received 0.1481 shares of Elanco common stock and one contingent value right (CVR) for each share of Aratana common stock. The CVR of $0.25 per Aratana share will be paid in cash if capromorelin achieves certain sales levels on or before the end of 2021. Elanco will update the investment community as milestones are met.